Leadership changeRegulatory filing
What was reported
The annual meeting of the stockholders of ClearPoint Neuro, Inc. (the “Company”) was held on May 20, 2026 (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted to approve the adoption of the ClearPoint Neuro, Inc. Seventh Amended and Restated 2013 Incentive Compensation Plan (the “Plan”). The Company’s Board of Directors (the “Board”) had previously adopted and approved the Plan, subject to stockholder approval.U.S. Securities and Exchange Commission (EDGAR) · 8-K: 8-K · May 21, 2026 · Open the source ↗
What the evidence supports
ClearPoint Neuro told the SEC (Form 8-K, Item 5.02) that there was a change involving its directors or officers, or their pay arrangements. The filing gives May 20, 2026 as the date of the earliest event reported.
What remains unknown
The reasons for the change beyond those stated, and what it means for the company's strategy or results.
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Form 8-K, Item 5.02 textThe annual meeting of the stockholders of ClearPoint Neuro, Inc. (the “Company”) was held on May 20, 2026 (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted to approve the adoption of the ClearPoint Neuro, Inc. Seventh Amended and Restated 2013 Incentive Compensation Plan (the “Plan”). The Company’s Board of Directors (the “Board”) had previously adopted and approved the Plan, subject to stockholder approval.U.S. Securities and Exchange Commission (EDGAR) · 8-K: 8-K · May 21, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:52 UTC
ClearPoint Neuro reports changes involving its directors or officers (Form 8-K, Item 5.02)
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.